← 產業報告目錄
Cancer Registry Software Market Size, Share & Trends Analysis Report By Software Type (Standalone Software, Integrated Software), By Database (Public data, Commercial data), By Deployment Model (Cloud-based, On-premises), By Functionality, By End-User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-31頁數 180報告編號 INSIGHTACE-9f374d6bba
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Cancer Registry Software Market on a global scale was estimated at USD 84.3 Mn in 2024 and is set to attain USD 282.9 Mn by 2034, with a projected CAGR of 13.0% between 2025 and 2034.
Cancer Registry Software covers reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cancer Registry Software Market Snapshot
Chapter 4. Global Cancer Registry Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Standalone Software
5.2.2. Integrated Software
Chapter 6. Market Segmentation 2: By Deployment Model Estimates & Trend Analysis
6.1. By Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Deployment Model:
6.2.1. On-premises
6.2.2. Cloud-based
Chapter 7. Market Segmentation 3: By Database Estimates & Trend Analysis
7.1. By Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Database:
7.2.1. Commercial Databases
7.2.2. Public Databases
Chapter 8. Market Segmentation 4: By Functionality Estimates & Trend Analysis
8.1. By Type & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Functionality:
8.2.1. Cancer Reporting to Meet State & Federal Regulations
8.2.2. Patient Care Management
8.2.3. Product Outcome Evaluation
8.2.4. Medical Research and Clinical Studies
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By Type & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
9.2.1. Government Organizations & Third-party Administrators (TPAS)
9.2.2. Hospitals & Medical Practices
9.2.3. Pharmaceutical, Biotechnology, & Medical Device Companies
9.2.4. Private Payers
9.2.5. Research Centers
Chapter 10. Cancer Registry Software Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
10.1.2. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Deployment Model, 2021-2034
10.1.3. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Database, 2021-2034
10.1.4. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By, Functionality, 2021-2034
10.1.5. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By, End User, 2021-2034
10.1.6. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.1.6.1. U.S.
10.1.6.2. Canada
10.2. Europe
10.2.1. Europe Cancer Registry Software Market revenue (US$ Million) By Type, 2021-2034
10.2.2. Europe Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Deployment Model, 2021-2034
10.2.3. Europe Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Database 2021-2034
10.2.4. Europe Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Functionality, 2021-2034
10.2.5. North America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.2.6. Europe Cancer Registry Software Market revenue (US$ Million) by country, 2021-2034
10.2.6.1. Germany
10.2.6.2. Poland
10.2.6.3. France
10.2.6.4. Italy
10.2.6.5. Spain
10.2.6.6. UK
10.2.6.7. Rest of Europe
10.3. Asia Pacific
10.3.1. Asia Pacific Cancer Registry Software Market revenue (US$ Million) By Type, 2021-2034
10.3.2. Asia Pacific Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Deployment Model, 2021-2034
10.3.3. Asia Pacific Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Database, 2021-2034
10.3.4. Asia Pacific Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Functionality 2021-20
10.3.5. Asia Pacific Cancer Registry Software Market revenue (US$ Million) estimates and forecasts End User, 2021-20
10.3.6. Asia Pacific Cancer Registry Software Market revenue (US$ Million) by country, 2021-2034
10.3.6.1. China
10.3.6.2. India
10.3.6.3. Japan
10.3.6.4. Australia
10.3.6.5. Rest of Asia Pacific
10.4. Latin America
10.4.1. Latin America Cancer Registry Software Market revenue (US$ Million) By Type, 2021-2034
10.4.2. Latin America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Deployment Model, 2021-2034
10.4.3. Latin America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Database, 2021-2034
10.4.4. Latin America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Functionality, 2021-2034
10.4.5. Latin America Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.4.6. Latin America Cancer Registry Software Market revenue (US$ Million) by country, (US$ Million) 2021-2034
10.4.6.1. Brazil
10.4.6.2. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Middle East & Africa Cancer Registry Software Market revenue (US$ Million) by Type Of Material, (US$ Million)
10.5.2. Middle East & Africa Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Deployment Model, 2021-2034
10.5.3. Middle East & Africa Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Database, 2021-2034
10.5.4. Middle East & Africa Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By Functionality, 2021-2034
10.5.5. Middle East & Africa Cancer Registry Software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.5.6. Middle East & Africa Cancer Registry Software Market revenue (US$ Million) by country, (US$ Million) 2021-2034
10.5.6.1. South Africa
10.5.6.2. GCC Countries
10.5.6.3. Rest of MEA
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1.1. Elekta (Sweden)
11.2.1.2. Electronic Registry Systems, Inc. (US)
11.2.1.3. Onco, Inc. (US)
11.2.1.4. C/NET Solutions (US)
11.2.1.5. Rocky Mountain Cancer Data Systems (US)
11.2.1.6. McKesson Corporation (US)
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們